摘要
背景:虽然已知视网膜色素上皮(RPE)细胞分泌VEGF-A和VEGFR 2,但VEGF自分泌信号的功能尚不清楚。同时,抗血管内皮生长因子(VEGF)治疗也已被广泛应用于眼部血管疾病的治疗.目的:探讨血管内皮生长因子(VEGF)信号传导通路在RPE细胞中的作用及其阻断的作用。方法:用siRNAs对Arpe-19细胞和人原发性RPE细胞进行瞬时转染,敲除VEGF和Hippo信号通路相关基因,通过腺病毒转导介导VEGFR 2的过度表达。采用实时PCR和westernblot方法检测YAP上皮间充质转换(EMT)标记和下游基因的表达。免疫荧光染色法检测组织和小鼠组织中基因的表达。结果:VEGFR 2基因敲除后,在体外和体内均发生上皮间充质转化。VEGFR 2的过表达抑制了转化生长因子β介导的视网膜色素上皮细胞移植。VEGF-C的丢失而不是VEGF-A的丢失导致EMT的发生.机械地说,VEGFR 2消融诱导的RPE细胞EMT是通过激活Hippo通路的效应物YAP而介导的。VEGFR 2和YAP在人增生性玻璃体视网膜病变(PVR)膜中的免疫组化分析显示VEGFR 2阳性细胞与YAP阳性细胞呈负相关。结论:VEGFR 2和VEGF-2在RPE细胞EMT和Hippo通路中具有新的作用。结果表明,VEGFR 2和VEGF-C对维持RPE细胞的正常生理状态具有重要意义。
关键词: 视网膜色素上皮细胞,上皮间充质转换,Hippo通路,YES相关蛋白,血管内皮生长因子,VEGFR 2,眼睛。
Current Molecular Medicine
Title:VEGFR2 and VEGF-C Suppresses the Epithelial-Mesenchymal Transition Via YAP in Retinal Pigment Epithelial Cells
Volume: 18 Issue: 5
关键词: 视网膜色素上皮细胞,上皮间充质转换,Hippo通路,YES相关蛋白,血管内皮生长因子,VEGFR 2,眼睛。
摘要: Background: Whereas retinal pigment epithelial (RPE) cells are known to secrete VEGF-A and VEGFR2, the functions of the autocrine VEGF signaling remain unclear. Meanwhile, anti-VEGF therapies have been applied routinely to treat ocular vascular diseases.
Objective: The aim of this study was to determine the functions of the VEGF signaling in RPE cells and evaluate the consequences of its interruption.
Methods: The genes involved in the VEGF and Hippo signal pathways were knocked down with siRNAs in both ARPE-19 cell line and human primary RPE cells via transient transfection whereas overexpression of VEGFR2 was mediated via adenovirus transduction. Expression of the epithelial-mesenchymal transition (EMT) markers and the downstream genes of YAP were determined by real-time PCR and Western Blot analysis. Immunofluorescence staining was utilized to determine gene expression in tissue and mouse samples.
Results: Knockdown of VEGFR2 results in epithelial-mesenchymal transition in vitro and in vivo. Overexpression of VEGFR2 suppresses TGF β-mediated EMT in RPE cells. Loss of VEGF-C rather than VEGF-A induces EMT. Mechanistically, the VEGFR2 ablation-induced EMT in RPE cells is mediated by activation of YAP, an effector of the Hippo pathway. Finally, the immunohistochemical analysis of VEGFR2 and YAP in human proliferative vitreoretinopathy (PVR) membranes indicates a tendency of an inverse correlation between VEGFR2-positive and YAP-positive cells.
Conclusions: Our results disclose unexpected novel roles of VEGFR2 and VEGF-C in the process of EMT of RPE cells and in the Hippo pathway. The data shown here demonstrated that VEGFR2 and VEGF-C are important to maintain the normal physiological state of RPE cells.
Export Options
About this article
Cite this article as:
VEGFR2 and VEGF-C Suppresses the Epithelial-Mesenchymal Transition Via YAP in Retinal Pigment Epithelial Cells, Current Molecular Medicine 2018; 18 (5) . https://dx.doi.org/10.2174/1566524018666181004115304
DOI https://dx.doi.org/10.2174/1566524018666181004115304 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Risk Factors for Development of Heart Failure
Current Cardiology Reviews Evaluation of Salivary Antioxidants and Oxidative Stress Markers in Male Smokers
Combinatorial Chemistry & High Throughput Screening Current Management of Extracranial Carotid Artery Disease
Reviews on Recent Clinical Trials Ovulation, Implantation and Placentation in Females with Obesity and Metabolic Disorders: Life in the Balance
Endocrine, Metabolic & Immune Disorders - Drug Targets High Altitude Hypoxia
Current Proteomics The Role of the Heme Oxygenase System in the Metabolic Syndrome
Current Pharmaceutical Design Glycemic Variability, Oxidative Stress, and Impact on Complications Related to Type 2 Diabetes Mellitus
Current Diabetes Reviews Current Evidence for Antithrombotic Therapy after Peripheral Vascular Interventions
Current Vascular Pharmacology History, Prevalence and Assessment of Limited Joint Mobility, from Stiff Hand Syndrome to Diabetic Foot Ulcer Prevention: A Narrative Review of the Literature
Current Diabetes Reviews Metabolic Effects of Resveratrol in Mammals - a Link Between Improved Insulin Action and Aging
Current Aging Science Perioperative Management of Patients on Adenosine Diphosphate Inhibitors in the Era of Drug-Eluting Stents: Review of the Literature and Clinical Implications
Current Medicinal Chemistry Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
Current Neuropharmacology The Prothrombotic State in Hypertension and the Effects of Antihypertensive Treatment
Current Pharmaceutical Design Ferritin and Percent Transferrin Saturation Levels Predict Type 2 Diabetes Risk and Cardiovascular Disease Outcomes
Current Diabetes Reviews Hormones and Sarcopenia
Current Pharmaceutical Design Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology Editorial [Hot Topic: Contrast Media: Induction of Side Effects and Pharmacological Treatment (Guest Editors: Ingrid Bohm & Hans H. Schild)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Lipid Metabolism and Relevant Disorders to Female Reproductive Health
Current Medicinal Chemistry HDL-C Levels and Cardiovascular Disease: More is not Always Better!
Recent Patents on Cardiovascular Drug Discovery